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ABSTRACT
Blighia sapida (BS) has been shown to be rich sources of 
antioxidant, thus, we evaluated eff ects of B. sapida Koenig 
stem bark ethanol extract (BSE) on lipid metabolism and he-
matological indices in diabetes rats.
Th irty male rats were divided into six groups of fi ve rats 
each. Diabetes was elicited by intraperitoneal injection of al-
loxan (65 mg/kg body weight) once and orally administered 
with glibenclamide (5 mg/kg), B. sapida extract (50, 100 and 
150 mg/kg body weight (bw) once daily for 21 days. Serum 
lipid profi le, markers of hepato-renal toxicity and hemato-
logical indices were examined using automated analyzer. 
Data were analyzed using one-way ANOVA and p < 0.05 
was considered to be statistically diff erent.
Diabetic untreated animals showed considerably elevated 
total cholesterol p < 0.05, also, signifi cant increase in AST, ALT, 
ALP, urea and creatinine compared to control. Triglycerides, 
LDL-c, VLDL-c, AI and CRI decreased with extract administra-
tion and HDL-c increased considerable compared to untreated 
diabetic rats. Furthermore, signifi cant lower hemoglobin (Hb) 
levels, packed cell volume (PCV), red blood cells (RBCs) levels, 
white blood cells (WBCs) compared to normal animals was re-
corded in the untreated group. Th ese changes were returned to 
normal after the administration of extract 50, 100 and 150 mg/
kg body weight. Hence, these eff ects were most prominent in the 
animals treated with 150 mg/kg body weight of B. sapida bark.
Th is indicates that B. sapida stem bark possess anti-hy-
perlipidemic activity and improved the biochemical param-
eters within the hematological profi le of diabetic rats.
Keyword: Blighia sapida, antihyperlipidemic, hemato-
logical profi le, diabetes
SAŽETAK
Poznato je da je Blighia sapida (BS) bogati izvor anti-
oksidanasa, stoga smo ispitivali efekte etanolnog ekstrakta 
B. sapida Koenig stem bark (BSE) na metabolizam lipida i 
hematološke indekse kod pacova sa dijabetesom.
Trideset pacova muškog pola bilo je podeljeno u šest grupa, 
po pet pacova u svakoj. Dijabetes je indukovan intraperitoneal-
nom injekcijom aloksana (65 mg/kg telesne mase) tokom 21 dana 
i oralno je primenjivan glibenklamid (5mg/kg) i B. sapida ekstrakt 
(50, 100 i 150 mg/kg telesne mase (tm)) jednom dnevno tokom 21 
dana. Serumski lipidni profi l, markeri hepato-renalne toksično-
sti i hematološki indeksi su odredjivani korišćenjem automatskog 
analizatora. Podaci su analizirani pomoću jednofaktorske anali-
ze varijanse (ANOVA) i p<0.05 se smatralo statistički značajnim.
Netretirane životinje sa dijabetesom su imale značajno 
povišen ukupni holesterol (p < 0.05) i takodje značajno pove-
ćanje AST, ALT, uree i kreatinina u poređenju sa kontrolom. 
Trigliceridi, LDL-c, VLDL-c, AI i CRI su se smanjili nakon 
administracije ekstrakta, a HDL-c se značajno povećao u 
odnosu na netretirane pacove sa dijabetesom. Osim toga, 
značajno niži nivo hemoglobina (Hb), hematokrit (PCV), 
broj eritrocita (RBCs), broj leukocita (WBCs) u poređenju sa 
zdravim životinjama je zabeležen u netretiranoj grupi. Ove 
vrednosti su se vratile u normalu nakon administracije 50, 
100 i 150 mg/kg tm ekstrakta. Ovi efekti su bili najizraženiji 
kod životinja tretiranih sa 150 mg/kg tm B. sapida bark.
Ovo ukazuje da B. sapida stem bark poseduje antihiperli-
pidemijsku aktivnost i da poboljšava biohemijske parametre u 
okviru hematološkog profi la kod dijabetičnih pacova. 
Ključne reči: Blighia sapida, antihiperlipidemijska aktiv-
nost, hematološki profi l, dijabetes
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ABBREVIATIONS
ALT: alanine transaminase;
AST: aspartate transaminase;
ALP: alkaline transaminase;
DM: diabetes mellitus;
BS: Blighia sapida;
TG: Triglycerides;
TC: Total cholesterol;
LDL-c: low density lipoprotein cholesterol;
HDL-c: high density lipoprotein cholesterol;
VLDL-c: very low density lipoprotein;
Hb: hemoglobin;
MCHC: mean corpuscular hemoglobin concentration
MCV: mean corpuscular volume;
RBC: red blood cells,
PCV: packed cell volume;
WBC: white blood cells.
2INTRODUCTION
Diabetes mellitus (DM) is a metabolic disturbance de-
fined by hyperglycemia caused by lack of insulin or disrup-
tion of insulin signaling as a result of lack of hypoglycemic 
agent or insensitivity of insulin hormone. DM is related to 
aberrant metabolism of macromolecules [1, 2, 3]. The ill-
ness happens as a results of exocrine gland β-cells injury, 
resulting in decreased secretion of insulin. It might con-
jointly arise once the receptors are resilient to the roles of 
insulin [4]. Hyperglycemia reoccurrence during diabetes 
leads to body proteins being glycated, that successively re-
sults in complications affecting body organs and arteries 
[5]. Stiffening of red blood cells could be liable for and or 
related to, large vessel disease in diabetes state [6]. Manage-
ment option for DM is predicated on insulin therapy and 
oral hypoglycemic agents that have several facet effects [7]. 
In diabetes state, the effects and locations of involvement 
in biochemical activity are varied and elevated serum total 
triglyceride level, increase level of transaminase, creatinine 
and urea are of concerned [6]. Additional major issue, that 
confounds diabetic state, leading to death is hyperlipidemia 
[8]. Different ways to this fashionable pharmacotherapy of 
diabetes mellitus are desperately required, attributed to the 
lack of accessible therapies to manage all the pathological 
basis of the ailment, in addition to the mammoth cost and 
poor accessibility for several populations in the developing 
world [6]. Therefore, plants use as medical aid for diabetes 
is inspired and acclaimed, though, a number of them are 
lacking scientific examination. 
Blighia sapida K.D. Koenig, also known as ‘Akee apple’ 
in English, belongs to the plant family called Sapindaceae 
and it is noted for its highly characteristic reddish fruits. 
The species in this family include B. sapida K.D. Koenig, 
B. unijugata Baker, and B. welwitschii (Hiern) Radlk. It is 
recognized as ‘isin’ in Yoruba, ‘gwanja kusa’ in Hausa and 
‘okpu’ in Igbo [9]. B. sapida K.D. Koenig is distributed 
throughout Nigeria [10]. B. sapida could be a therapeutic 
herbal plant ordinarily utilized by trado-medical healers 
in Nigeria, and highly appreciated in West Africa for the 
management of various diseases like diabetes mellitus [11]. 
The fruit has inhibitory effect against α-glucosidase and 
α-amylase as reported by Kazeem et al. [12]. B. sapida root 
extract has been shown to possess normoglycemic impact 
[13]. The stem bark has been shown to ameliorate pan-
creatic β-cell dysfunction in diabetic rats [11]. Therefore, 
this study was focused on analyzing the effects of Blighia 
sapida K.D. Koenig stem bark on antihyperlipidemic and 
hematological parameters in diabetic rats.
METHODS
Plant material
Fresh stem bark peelings of B. sapida Koenig was ob-
tained at a farm in the suburbs of Abeokuta, Ogun State, 
Nigeria. The plant was identified and authenticated by a 
senior taxonomist at the university herbarium with her-
barium approval number (UHAE/2016/020). All plant 
names in this manuscript are formatted according to the 
latest revision in “The Plant List” (www.theplantlist.org).
Plant extracts preparation
Stem bark was air-dried in the laboratory at tempera-
ture (25 ± 2°C), pulverized using an electrical blender and 
the powders obtained stored till further use. The small 
grained sample (100 g) was extracted with solvent combi-
nation of 70% ethanol for 48 h. The extract was filtered and 
thereafter evaporated to dryness using rotary evaporator 
[14]. The concentrated extract was stored at 4 °C until fur-
ther analysis. The extraction yield is as follows.
                               Weight of the extract 
Percentage yield = —————————————————  x 100 % [15]
                                     Weight of powdered stem bark 
The percentage yield of the extraction was 19.1 %.
Experimental Animals
Six-week-old male Wistar rats with an initial mean 
body weight of 150 ± 50 g were obtained from Animal 
house Afe Babalola University, Ado-Ekiti, Ekiti State, 
Nigeria. The animals were divided into six groups of 
five each and adapted to investigational condition for 
two weeks. The animals were housed in clean meta-
bolic cages that provided free access to water and rat 
pellets (Ladokun Feeds, Nigeria). The principles of 
Animal Care (Public Health Services, 1986) was moni-
tored through the duration (for twenty-one days) of 
the experiment. The standards of National Institute of 
Health (NIH publication 85-23, 1985) for experimental 
maintenance and handling of animals was conformed 
to [16]. The ethical committee of the Afe Babalola 
University approved this study with approval number 
(ABUAD/ACA/121). The rats in this study followed 
the rules of the established Animal Ethical Committee 
of Afe Babalola University.
Animal grouping
The animals were randomly divided into six groups of 
5 animals namely;
 
Normal control group (distilled water), 
Diabetic untreated group (65 mg/kg Alloxan, intraperitoneal) 
Diabetic + 5 mg/kg bw
Diabetic + 50 mg/kg bw BSE, oral gavage 
Diabetic + 100 mg/kg bw BSE, oral gavage 
Diabetic + 150 mg/kg bw BSE, oral gavage 
Dose dependent study was previously carried out in 
our laboratory with three different doses of BSE (50, 100 
and 150 mg/kg body weight) based on ethnobotanical sur-
vey conducted by [11].
3Induction of diabetes
In induction of diabetes, alloxan (65 mg/kg body weight) 
was dissolved in sterile physiological saline and intraperi-
toneal injected (5.6 mL) into the animals in the diabetic 
control, diabetic + glibenclamide (5 mg/kg body weight), 
diabetic + 50 mg/kg body weight of BSE (2.5 mL), diabetic 
+ 100 mg/kg body weight of BSE (5.5 mL), diabetic + 150 
mg/kg body weight of BSE (8.5 mL) groups to induce β-cell 
dysfunction. This was done in morning after the rats have 
been fasted overnight, while the animals in normal control 
group received a similar volume of distilled water. Forty-
eight hours after induction, fasting blood glucose (FBG) 
of all rats were measured by collecting blood from the tail 
vein using a portable glucometer. Animals with a FBG lev-
el ≥ 200 mg/dl were considered as diabetic while animals 
with a FBG level < 200 mg/dl were disqualified [17].
Collection of blood
Under di ethyl anaesthesia, the neck area of the rats was 
quickly cleared to expose the jugular veins. Blood samples 
from each animal was collected after 21 days through their 
jugular vein and preserved until further processing. The 
blood sample was collected into a dry tube and allowed to 
clot for 30 min before centrifuging at 3500 rpm for 10 min 
to collect the serum for further study [18].
Biochemical parameters
Serum lipid concentrations, in additional to aspartate 
and alanine aminotransferases and alkaline phosphatase 
as well as urea and creatinine concentrations were assayed 
using commercially available kits (DRG Diagnostics, USA) 
according to manufacturer’s protocol.
Low density lipoprotein-cholesterol was estimated ac-
cording to equation as shown below:
LDL-cholesterol (mg/dl) = TC- HDL- (TG/5)
Non-HDL-cholesterol (mg/dl) = TC – HDL-cholesterol
Whereas, TG/5 is equivalent to the concentration of 
very low density lipoprotein. VLDL means very low density 
lipoprotein, TG means triacylglycerol
Atherogenic index (AI) was calculated and expressed 
as:
                                          TC-HDL-cholesterol
Atherogenic index (AI) = —————————————    
                                                     HDL-cholesterol
Coronary artery risk index (CRI) was deduced using 
the formula below.
                                                                TC (mg/dl)
Coronary artery risk index (CRI) = —————————————    
                                                                   HDL-cholesterol (mg/dl)
Whereas, HDL means high density lipoprotein-choles-
terol, TC means total cholesterol
Hematological analysis
The hematological parameters like packed cell volume 
(PCV), hemoglobin (Hb), WBC count and WBC percent-
age composition, mean corpuscular hemoglobin (MCH), 
mean corpuscular hemoglobin concentration (MCHC) 
and mean corpuscular volume (MCV) were analysed by 
means of an automated analyzer (Sysmex K-2 IN, Japan). 
Total white blood cell counts (WBC) was analysed by 
the hemocytometer method, whereas smears were ready 
and marked by using Leishman technique and numbered 
by the longitudinal counting method to resolve differen-
tial count. Packed cell volume (PCV) was analyzed by the 
micro-haematocrit method while hemoglobin (Hb) levels 
was assessed by the cyano methemoglobin method [19]. 
Data analysis
Data are presented as the mean ± SD (n=5). The data 
were analyzed by one-way analysis of variance via a statis-
tical software package (SPSS, Version 20.0, IBM Corpora-
tion, NY, USA) one-way ANOVA using Duncan multiple 
range post-hoc test (DMRT). Values were considered to be 
significantly different at p < 0.05. 
RESULTS
The effect of Blighia sapida stem bark ethanol extract 
on fasting blood glucose level of alloxan-induced diabetic 
rats is presented in Table 1. Fasting blood glucose levels 
in all animals induced with alloxan was significantly in-
creased, compared to the normal control group, p < 0.05. 
The fasting blood glucose levels were however, reduced 
considerably in diabetic + 50 mg/kg body weight of BSE, 
diabetic + 100 mg/kg body weight of BSE and diabetic + 
150 mg/kg body weight of BSE groups in addition to glib-
enclamide treated animals. 
Table 1: Eff ects of ethanol extract Blighia sapida stem bark on the fasting blood glucose level of alloxan-induced diabetic rats 
Groups Initial fasting blood glucose level (mg/dl) Fasting blood glucose at 48 h after induction (mg/dl)
Final fasting blood glucose at 
21 days after induction (mg/dl)
Control 86.10 ± 0.14a 85.65 ± 0.10a 87.20 ± 1.14a
Diabetic control 86.48  ± 1.01a 287.10 ± 1.01b 364.10 ± 2.10d
Diabetic + glibenclamide 84.02  ± 1.96a 244.20 ± 1.45e 88.40  ± 1.0a
Diabetic + 50 mg/kg B.S 85.46  ± 1.42a 287.10 ± 1.12e 102.10 ± 1.10c
Diabetic + 100 mg/kg B.S 84.49  ± 1.20a 306.46 ± 1.24d 96.96 ± 2.10b
Diabetic + 150 mg/kg B.S 86.10 ± 1.32a 386.12 ± 2.12d 88.201 ± 1.10a
Data are presented as the mean ± SEM of 5 animals. Values with diff erent superscript letters (a-e) along a column for a given parameter are signifi cantly 
diff erent from each other between groups at P < 0.05. 
4Serum lipid concentrations, calculated atherogenic in-
dex (AI) and coronary risk index (CRI) scores are displayed 
in Table 2. High serum concentrations of TC, TG, LDL-
cholesterol and non-HDL-cholesterol levels in addition to 
analyzed AI and CRI scores with progressive decrease in 
serum HDL-cholesterol were observed within diabetic un-
treated group compared to the normal control. Adminis-
tration with B. sapida stem bark ethanol extract to diabetic 
animals considerably and dose-dependently abridged TC, 
TG and LDL-cholesterol levels, AI and CRI in 50 ,100 and 
150 mg/kg bw of BSE and glibenclamide groups compared 
with the diabetic untreated. Although considerably in-
crease in serum HDL-cholesterol level was observed in the 
B. sapida K.D. Koenig stem bark ethanol extract treated 
groups compared to the diabetic untreated.
Serum ALT, AST, ALP, urea and creatinine levels are 
presented in Table 3. Concentrations of serum ALT, AST, 
ALP, urea and creatinine levels were considerably increased 
within the diabetic untreated compared to the normal con-
trol. On the other hand, administration of B. sapida stem 
bark ethanol extract to diabetic animals progressively ame-
liorated these changes in 50, 100 and 150 mg/kg bw of BSE 
and glibenclamide treated groups. 
Hemoglobin (Hb) levels, packed cell volume (PCV) 
count, red blood cells (RBCs), white blood cells (WBCs), 
mean corpuscular hemoglobin concentration (MCHC), 
mean corpuscular volume (MCV), mean corpuscular he-
moglobin (MCH), neutrophils (N), lymphocyte (L), mono-
cytes (M) and eosinophils (E) are displayed in Table 4. 
Hemoglobin (Hb) levels, packed cell volume (PCV), red 
blood cells (RBCs) levels, white blood cells (WBCs), mean 
corpuscular haemoglobin concentration (MCHC), mean 
corpuscular volume (MCV), mean corpuscular haemoglo-
bin (MCH), neutrophils (N), lymphocyte (L), monocytes 
(M) and eosinophils (E) were evidently reduced in diabetic 
untreated compared to normal control. Though, adminis-
tration of 50-150 mg/kg bw of BSE groups demonstrated a 
considerably increase on the biochemical parameters men-
tioned above. Glibenclamide treatment conjointly consid-
erably increase these biochemical parameters. 
DISCUSSION
In this study, we examined the effect of oral adminis-
tration of B. sapida Koenig stem bark ethanol extract in 
diabetic rats through twenty-one days’ post-treatment pe-
riod. The typical characteristics of diabetic dyslipidemia 
include high serum cholesterol, triglyceride (hypertriglyc-
erolemia), LDL-cholesterol concentrations and low HDL-
Table 2: Eff ect of administration of ethanol extract of Blighia sapida stem bark on Serum lipid profi les, atherogenic and coronary risk indices of 
alloxan-induced diabetic rat
Groups TC (mg/dl) TG (mg/dl) LDL (mg/dl) VLDL (mg/dl) Non-HDL (mg/dl) HDL (mg/dl) AI CRI
Control 56.28±1.04a 40.21±0.02a 19.39±0.01a 8.04±0.01a 27.44±0.98a 28.84±0.01a 0.95±0.02a 1.95±0.01a
DC 95.84±0.12e 104.26±0.14d 64.91±0.21d 20.85±0.12d 85.76±1.22e 10.08±0.02e 8.51±1.01d 9.51±1.22d
DC + gliben-
clamide 62.20±0.14
d 53.12±1.12c 33.39±1.11c 10.62±0.04c 44.01±0.67c 18.19±0.30d 2.42±0.33c 3.42±0.31c
Diabetic rats + 
50mg/kg BSE 64.32±1.20
c 54.36±1.18c 33.33±1.08c 10.87±0.38c 44.20±0.01c 20.12±0.14c 2.20±0.41c 3.19±0.58c
Diabetic rats + 
100mg/kg BSE 69.92±1.10
b 44.10±0.06b 34.98±0.04b 8.82±0.25a 44.80±0.45b 25.12±0.06b 1.74±0.30b 2.78±0.28b
Diabetic rats + 
150mg/kg BSE 55.89±1.48
a 40.82±1.06a 18.74±0.05a 8.16±0.01a 26.91±1.12a 28.98±1.01a 0.93±0.01a 1.93±0.02a
Data are presented as the mean ± SEM of 5 animals. Values with diff erent superscript letters (a-e) along a column for a given parameter are signifi cantly 
(P < 0.05) diff erent from each other. TC, Total cholesterol; TG, Triglyceride; LDL-cholesterol, Low density lipoprotein-cholesterol; HDL-cholesterol; 
High density lipoprotein-cholesterol, AI; atherogenic index, CRI; coronary artery index.
Table 3: Eff ect of administration of ethanol extract of Blighia sapida stem bark on selected biomolecules of alloxan-induced diabetic rat 
Groups AST (μ/l) ALT (μ/l) Urea (mg/dl) Creatinine (mg/dl) ALP (μ/l) Total Bilirubin (mg/dl)
Control 96.48±0.14a 62.20±1.02a 26.11±1.16a 4.00±1.22a 164.14±2.10a 6.10±1.10a
Diabetic Control 180.20±2.12e 100.20±1.42e 56.43±2.43e 10.39±2.08e 482.01±4.07e 18.14±2.10d
Diabetic rats + Glibenclamide 140.40±1.20d 84.20±2.04d 42.12±3.46d 6.04±1.12d 240.11±3.17d 10.42±1.19c
Diabetic rats + 50mg/kg BS 110.20±1.05c 76.40±1.04c 38.36±4.69c 6.47±1.12c 210.14±1.64+c 8.14±2.48b
Diabetic rats + 100mg/kg BS 102.34±34b 72.49±1.80b 30.48±2.04b 5.29±1.15b 180.13±3.01b 8.04±1.10b
Diabetic rats + 150mg/kg BS 96.84±1.04a 61.84±1.42a 26.92±3.11a 4.13±1.06a 168.89±3.19a 6.32±2.10a
Data are presented as mean ± SEM of 5 animals. a-e Values with diff erent superscript letters along a column for a given parameter are signifi cantly dif-
ferent from each other group of animals. BS, Blighia sapida; ALT, Alanine transaminase; AST, Alanine transaminase; ALP, Alkaline phosphate.
5cholesterol (hypercholesterolemia) contents [20]. Like-
wise, the increase levels of LDL-C and atherogenic index 
by the alloxan indicates predisposition to cardiovascular 
risk [21]. The significant elevation in cholesterol, triacylg-
lycerol and LDL-cholesterol concentrations in the diabetic 
rats treated with distilled water may be owing to improved 
mobilization of free fatty acids from the peripheral fat de-
pots. This obvious hyperlipidemia that describe the dia-
betic state may hence be considered as a consequence of 
uninhibited actions of lipolytic hormones on the fat depots 
[22]. Aberrant lipid metabolism, resulting in amassing of 
LDL-C, VLDL and total cholesterol in addition to reduced 
HDL-cholesterol, is often related to diabetes mellitus [23]. 
Elevated levels of LDL, VLDL, atherogenic index, coronary 
artery index and total cholesterol are thought of as main 
menace for cardiovascular disease (CVD). On the contrary, 
elevated HDL-cholesterol that functions in the transport 
of cholesterol from the periphery to the liver reduces the 
chance of CVD [24]. Oral intervention of B. sapida stem 
bark ethanol extract and the standard drug both averts 
dyslipidemia, decreases the chance of developing athero-
genesis and coronary artery disease and amplified serum 
HDL-cholesterol level. This is in accordance with newly 
published studies [8, 25, 26, 27].
Aminotransaminses are significant and key enzymes 
involved in the breakdown of amino acids into α-keto acid, 
which are directed for complete metabolism via the Krebs 
cycle and electron transport chain. They are considered 
exact biomarkers for liver damage [28]. In hepatocyte in-
jury, there is impairment in the biomembrane of liver cells 
which leads to permeability of cytoplasmic enzymes such 
as AST and ALT which leak into the circulatory system 
and result in significant elevation in their activities in se-
rum. Moreover, modification of membrane bound alkaline 
phosphatase (ALP) affects membrane permeability and 
produces imbalance in the transport of metabolites [29]. 
Elevated serum transaminase, alanine aminotransferase 
(ALT), aspartate aminotransaminse (AST), alkaline phos-
phatase (ALP), urea and creatinine levels are thought of as 
biomarkers of hepato-renal damage, related to liver disease 
and hyperglycaemia [30, 31]. Treatment with B. sapida 
stem bark ethanol extract at 50 - 150 mg/kg bw significant-
ly reduced (p < 0.05) ALT, AST, ALP, urea and creatinine 
levels, indicating that B. sapida bark might ameliorates 
alloxan-induced injury in diabetic rats. The considerably 
lower serum creatinine and urea levels in the B. sapida 
stem bark ethanol extract treated groups compared with 
diabetic untreated, indicates its doable impact on the bet-
terment of diabetes induced kidney injury [32, 33].
Vital reductions in haemoglobin (Hb) levels, packed cell 
volume (PCV), red blood cells (RBCs), white blood cells 
(WBCs), mean corpuscular haemoglobin concentration 
(MCHC), mean corpuscular volume (MCV), mean corpus-
cular haemoglobin (MCH), neutrophils (N), lymphocyte (L), 
monocytes (M) and eosinophils (E) were observed (p < 0.05) 
in the diabetic untreated rats. Substantial significant (p < 
0.05) increase in haematological parameters occurred upon 
administration of the B. sapida stem bark ethanol extracts 
at 50 - 150 mg/kg doses compared to the diabetic untreated 
rats. Constant trend was observed in the levels of param-
eters mention above for glibenclamide treated rats. Though 
these effect were more pronounced in the 150 mg/kg bw of 
BSE group [6, 34]. This may be as a result of the presence 
of metabolites like saponins, phenols and alkaloids [35 36, 
37]. Blood examination could be a great means of evaluating 
the well-being standing of animals because it performs sig-
nificant physiological and biological roles in organisms [38]. 
However, in diabetic state, the extra glucose present reacts 
with haemoglobin to produce glycated haemoglobin. This 
therefore shown that diabetic untreated rats displayed aber-
rations in the hematological profiles. A number of these ab-
errations may result in destruction of developed red blood 
cells resulting in the small Hb counts accompanied with the 
drop in the RBC and PCV [39, 40]. Extremely low values 
Table 4: Eff ect of administration of ethanol extract of Blighia sapida stem bark on haematological parameters of alloxan-induced diabetic rat 
Parameters Control Diabetic control DC + Glibenclamide Diabetic rats +50 mg/kg BSE
Diabetic rats + 
100 mg/kg BSE
Diabetic rats +
150 mg/kg BSE
PCV (%) 55.10±1.01a 27.10±1.01e 42.00±0.10d 48.10±1.01c 51.20±1.04b 55.84±2.02a
Hb (g/dl) 11.98±0.50a 6.14±0.02e 8.20±0.20d 9.58±0.32c 10.62±0.04b 11.64±0.52a
WBC (x w3/μl) 2.42±0.22a 0.45±0.14e 1.26±0.28d 1.69±0.46c 2.00±0.07b 2.44±0.84a
N (%) 49.20±1.12a 26.20±2.10e 36.21±0.14d 39.40±1.10c 46.24±0.12b 49.62±0.45a
L  (%) 30.11±0.01a 20.20±0.12d 24.03±0.12c 27.20±1.12b 28.20±1.02b 30.44±1.20a
M (%) 8.01±0.14a 4.28±0.18d 6.01±0.19c 6.99±0.14c 7.46±0.12b 8.46±0.26a
E (%) 3.01±0.11a 0.92±0.13d 1.49±0.16c 1.94±0.08c 2.46±0.02b 3.68±0.04a
RBC (xw11/l) 3.20±0.31a 0.80±0.04d 1.45±0.02c 1.64±0.42c 2.48±0.12b 3.48±0.06a
MCHC (g/dl) 34.10±0.06a 22.10±0.04d 28.41±1.10c 29.10±0.12c 32.41±0.02b 34.46±0.12a
MCV (fl ) 79.01±1.10a 54.12±0.16e 63.49±0.10d 69.10±0.52c 75.96±0.48b 79.60±0.09a
MCH (pg) 35.11±1.20a 24.01±0.06e 28.42±0.04d 30.20±0.44c 32.69±0.16b 35.64±1.10a
Data are presented as mean ± SEM of 5 animals.  Values with diff erent superscript letters (a-e) along a column for a given parameter are signifi cantly 
(P < 0.05) diff erent from each other group of animals. Haemoglobin (Hb), packed cell volume (PCV), red blood cells (RBCs), white blood cells (WBCs), 
mean corpuscular hemoglobin concentration (MCHC), mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), neutrophils (N), 
lymphocyte (L), monocytes (M) and eosinophils (E).
6of RBC, Hb and hematocrit might specify anemia [34, 39]. 
Furthermore, modulatory effect and confined toxicity might 
ensue as noted within the lymphocytes and neutrophils of 
the diabetic untreated animals. Administration of the B. sap-
ida stem bark ethanol extract stimulates positive changes in 
the hematological profile of the diabetic rats. Hence, up-
surge in RBC by the extract is a sign of its restorative impact 
on alloxan-induced anemia whereas the alteration in level of 
lymphocytes by the extract could specify an anti-infection 
activity [36, 40, 41].
CONCLUSION
The results from this study indicates that B. sapida 
ethanol stem bark extract possesses robust anti-diabetic 
activity via improving dyslipidemia and ameliorate ane-
mic condition in diabetic rats. Hence, ethanol extract of 
B. sapida K.D. Koenig stem bark could be a possible anti-
diabetic natural product with no significant side effects. 
Further studies to isolate the bioactive principles using 
HPLC, complete safety assessment as well as activities on 
metabolizing enzymes and pro-inflammatory biomarkers 
should be carried out in vivo. 
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